Search research articles
Contact Us
Filters
Showing results (261-270 of 276) with videos related to
Page
of 28
Sort By:
The Journal of Clinical Investigation
|
December 1, 2025
LC3-dependent intercellular transfer of phosphorylated STAT1/2 elicits CXCL9+ macrophages and enhances radiation-induced antitumor immunity
Jun-Yan Li, Ying-Qing Li, Jia-Hao Dai, et al.
Molecular Cancer
|
February 3, 2026
Fusobacterium nucleatum manipulates host autophagy to promote its intracellular survival and treatment resistance in nasopharyngeal carcinoma
Jing-Yun Wang, Ying-Qi Lu, Xi-Rong Tan, et al.
Medcomm
|
April 3, 2026
Circulating Microbial Metabolites Predict Tumor Relapse and Chemotherapy Efficacy in Nasopharyngeal Carcinoma
Jun-Yan Li, Yao Yao, Xi-Rong Tan, et al.
Journal of Pain and Symptom Management
|
November 13, 2025
Physicians' Perspectives and Attitudes Toward Palliative Care for Cancer Children in Mainland China
Anan Zhang, Xuan Zhou, Jianmin Wang, et al.
Cancer Research Communications
|
August 29, 2024
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer
Matthew T Campbell, Amishi Y Shah, Pavlos Msaouel, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2023
Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)
Bilal A Siddiqui, Brian F Chapin, Sonali Jindal, et al.
Nature Communications
|
November 5, 2021
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma
Matthew T Campbell, Surena F Matin, Alda L Tam, et al.
Science Translational Medicine
|
April 20, 2022
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy
Pavlos Msaouel, Sangeeta Goswami, Peter F Thall, et al.
Nature Communications
|
January 10, 2025
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial
Pavlos Msaouel, Kai Yu, Ying Yuan, et al.
Science Translational Medicine
|
July 15, 2026
Culturomics reveals <i>Fusobacterium</i>-<i>Prevotella</i> mutualism as a hallmark of nasopharyngeal tumor microbiota
Ying-Qi Lu, Jia-Hao Dai, Yu-Fei Duan, et al.
Page
of 28
Search research articles
Search
Showing results (261-270 of 276) with videos related to
Sort By:
Page
of 28
The Journal of Clinical Investigation
|
December 1, 2025
LC3-dependent intercellular transfer of phosphorylated STAT1/2 elicits CXCL9+ macrophages and enhances radiation-induced antitumor immunity
Jun-Yan Li, Ying-Qing Li, Jia-Hao Dai, et al.
Molecular Cancer
|
February 3, 2026
Fusobacterium nucleatum manipulates host autophagy to promote its intracellular survival and treatment resistance in nasopharyngeal carcinoma
Jing-Yun Wang, Ying-Qi Lu, Xi-Rong Tan, et al.
Medcomm
|
April 3, 2026
Circulating Microbial Metabolites Predict Tumor Relapse and Chemotherapy Efficacy in Nasopharyngeal Carcinoma
Jun-Yan Li, Yao Yao, Xi-Rong Tan, et al.
Journal of Pain and Symptom Management
|
November 13, 2025
Physicians' Perspectives and Attitudes Toward Palliative Care for Cancer Children in Mainland China
Anan Zhang, Xuan Zhou, Jianmin Wang, et al.
Cancer Research Communications
|
August 29, 2024
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer
Matthew T Campbell, Amishi Y Shah, Pavlos Msaouel, et al.
Journal for Immunotherapy of Cancer
|
March 22, 2023
Immune and pathologic responses in patients with localized prostate cancer who received daratumumab (anti-CD38) or edicotinib (CSF-1R inhibitor)
Bilal A Siddiqui, Brian F Chapin, Sonali Jindal, et al.
Nature Communications
|
November 5, 2021
Pilot study of Tremelimumab with and without cryoablation in patients with metastatic renal cell carcinoma
Matthew T Campbell, Surena F Matin, Alda L Tam, et al.
Science Translational Medicine
|
April 20, 2022
A phase 1-2 trial of sitravatinib and nivolumab in clear cell renal cell carcinoma following progression on antiangiogenic therapy
Pavlos Msaouel, Sangeeta Goswami, Peter F Thall, et al.
Nature Communications
|
January 10, 2025
Sitravatinib in combination with nivolumab plus ipilimumab in patients with advanced clear cell renal cell carcinoma: a phase 1 trial
Pavlos Msaouel, Kai Yu, Ying Yuan, et al.
Science Translational Medicine
|
July 15, 2026
Culturomics reveals <i>Fusobacterium</i>-<i>Prevotella</i> mutualism as a hallmark of nasopharyngeal tumor microbiota
Ying-Qi Lu, Jia-Hao Dai, Yu-Fei Duan, et al.
Page
of 28